Jeffrey E. Russel

Array ( [id] => 1239992 [patent_doc_number] => 06686334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Use of inhibitors of protein kinase C epsilon to treat pain' [patent_app_type] => B2 [patent_app_number] => 10/039278 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 29 [patent_no_of_words] => 10957 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686334.pdf [firstpage_image] =>[orig_patent_app_number] => 10039278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150245 [patent_doc_number] => 06770626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Tissue remodeling' [patent_app_type] => B2 [patent_app_number] => 10/032330 [patent_app_country] => US [patent_app_date] => 2001-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 21710 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770626.pdf [firstpage_image] =>[orig_patent_app_number] => 10032330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305886 [patent_doc_number] => 20040116342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Therapeutic uses of smri peptides' [patent_app_type] => new [patent_app_number] => 10/451064 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15006 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116342.pdf [firstpage_image] =>[orig_patent_app_number] => 10451064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472670 [patent_doc_number] => 07229969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Combinations of enzyme inhibitors and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/250476 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7151 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229969.pdf [firstpage_image] =>[orig_patent_app_number] => 10250476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351162 [patent_doc_number] => 20040048208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Silver-dispersing polypeptides' [patent_app_type] => new [patent_app_number] => 10/451897 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8040 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048208.pdf [firstpage_image] =>[orig_patent_app_number] => 10451897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782818 [patent_doc_number] => 06992066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'Povidone-containing carriers for polypeptide growth factors' [patent_app_type] => utility [patent_app_number] => 10/027669 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 7082 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/992/06992066.pdf [firstpage_image] =>[orig_patent_app_number] => 10027669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256062 [patent_doc_number] => 20040259806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Treatment of tuberculosis using immunomodulator compounds' [patent_app_type] => new [patent_app_number] => 10/485487 [patent_app_country] => US [patent_app_date] => 2004-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5858 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259806.pdf [firstpage_image] =>[orig_patent_app_number] => 10485487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051258 [patent_doc_number] => 20050187145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Template-fixed peptidommetics as inhibitors of serine proteases' [patent_app_type] => utility [patent_app_number] => 10/498468 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43245 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187145.pdf [firstpage_image] =>[orig_patent_app_number] => 10498468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750943 [patent_doc_number] => 20030045464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Glucagon-like peptide-1 crystals' [patent_app_type] => new [patent_app_number] => 09/997792 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8576 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045464.pdf [firstpage_image] =>[orig_patent_app_number] => 09997792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439822 [patent_doc_number] => 06495336 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Oligopeptide derivatives for the electrochemical measurement of protease activity' [patent_app_type] => B1 [patent_app_number] => 09/914259 [patent_app_country] => US [patent_app_date] => 2001-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6138 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 536 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495336.pdf [firstpage_image] =>[orig_patent_app_number] => 09914259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361274 [patent_doc_number] => 20020058627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein' [patent_app_type] => new [patent_app_number] => 09/989476 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6993 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058627.pdf [firstpage_image] =>[orig_patent_app_number] => 09989476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6834743 [patent_doc_number] => 20030162289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Peptides promoting cell adherence, growth and secretion' [patent_app_type] => new [patent_app_number] => 09/992124 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11275 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162289.pdf [firstpage_image] =>[orig_patent_app_number] => 09992124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1317504 [patent_doc_number] => 06608175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-19 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/991286 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 33695 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608175.pdf [firstpage_image] =>[orig_patent_app_number] => 09991286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6241314 [patent_doc_number] => 20020044929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Methods for treating sepsis' [patent_app_type] => new [patent_app_number] => 09/998393 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5479 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20020044929.pdf [firstpage_image] =>[orig_patent_app_number] => 09998393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6473215 [patent_doc_number] => 20020151493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Therapeutic agents and methods of use thereof for the modulation of angiogenesis' [patent_app_type] => new [patent_app_number] => 10/001945 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16985 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151493.pdf [firstpage_image] =>[orig_patent_app_number] => 10001945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385605 [patent_doc_number] => 20040082496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'ACE-2 modulating compounds and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/999781 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 100319 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 51 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082496.pdf [firstpage_image] =>[orig_patent_app_number] => 09999781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 459973 [patent_doc_number] => 07241737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Urotensin-II agonists and antagonists' [patent_app_type] => utility [patent_app_number] => 10/399542 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4602 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241737.pdf [firstpage_image] =>[orig_patent_app_number] => 10399542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7349288 [patent_doc_number] => 20040047861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof' [patent_app_type] => new [patent_app_number] => 10/399824 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 14196 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047861.pdf [firstpage_image] =>[orig_patent_app_number] => 10399824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1297876 [patent_doc_number] => 06623731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-23 [patent_title] => 'Compounds and compositions for delivering active agents' [patent_app_type] => B2 [patent_app_number] => 10/038426 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11019 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623731.pdf [firstpage_image] =>[orig_patent_app_number] => 10038426 [rel_patent_id] =>[rel_patent_doc_number] =>)